sur ADOCIA (EPA:ADOC)
ADOCIA concludes a financial agreement with Vester Finance
The French biopharmaceutical company ADOCIA has signed an agreement with Vester Finance for a shareholder current account advance. The two-year agreement provides a financing line of up to €6 million. €1.5 million has been disbursed immediately, with an option for repayment in shares or cash. This will allow ADOCIA to extend its cash runway until the beginning of the second quarter of 2027.
The funds will be used to develop the BioChaperone® and AdoXLong™ platforms. Vester Finance, which currently holds 4.2% of the company's capital, will see its stake increase significantly. This transaction is designed to strengthen ADOCIA's financial position while avoiding the requirement for a prospectus to be submitted to the AMF (French Financial Markets Authority).
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de ADOCIA